Welcome to our dedicated page for Vuzix SEC filings (Ticker: VUZI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to locate Vuzix’s waveguide patent numbers or defence contract revenue buried in a 300-page filing? Augmented-reality companies like Vuzix pack technical jargon, OEM commitments and R&D milestones into every report, making it tough to spot what moves the stock.
Stock Titan surfaces the answers instantly. Our AI reads each Vuzix quarterly earnings report 10-Q filing, Vuzix annual report 10-K simplified, and every Vuzix 8-K material event explained, then delivers plain-English highlights you can scan in seconds. Need real-time Vuzix Form 4 insider transactions? We alert you the moment executives file, so tracking Vuzix executive stock transactions Form 4 becomes effortless.
- AI-powered summaries that translate optical-physics disclosures into actionable numbers
- Real-time feed of all SEC submissions—10-K, 10-Q, 8-K, S-1, DEF 14A proxy statements for executive compensation
- Instant search answers to natural questions like “How much did Vuzix spend on R&D last quarter?” or “Show me Vuzix insider trading Form 4 transactions”
Whether you’re comparing segment sales, monitoring OEM revenue share or reviewing dilution from at-the-market offerings, our platform keeps every disclosure at your fingertips. Skip the PDF hunt, and start understanding Vuzix SEC documents with AI—from Vuzix earnings report filing analysis to detailed proxy statement executive compensation data—so you can make informed decisions faster.
Chris Parkinson, President of Vuzix Enterprise Solutions, reported insider grants on 09/29/2025. He was granted 150,000 shares of restricted common stock issued at no cash price and will own 152,250 shares following the transaction. In addition, he received 1,000,000 Restricted Stock Units (RSUs) that each represent the right to one share; those RSUs will vest only if specified revenue and EBITDA targets for the Enterprise Solutions business unit are met by December 31, 2028. The restricted shares will vest quarterly over one year.
Alasdair MacKinnon, a director of Vuzix Corp (VUZI), was granted 65,295 shares of restricted common stock on 08/05/2025. The Form 4 reports the acquisition at a reported price of $0, indicating a restricted stock grant rather than a market purchase. Following the grant MacKinnon beneficially owns 65,295 shares directly. The grant vests in three tranches: 45,295 shares vest on June 30, 2026, 10,000 shares vest on June 30, 2026, and 10,000 shares vest on June 30, 2027. The Form 4 is signed by MacKinnon on 09/25/2025.
Form 3 filed for Vuzix Corp (VUZI) by Alasdair John MacKinnon reports his initial beneficial ownership statement as a director. The filing shows 0 shares of common stock beneficially owned and indicates the form was required by an event on 08/05/2025. The submission is signed by the reporting person on 09/25/2025. No derivative securities or indirect ownership are disclosed.
Quanta Computer Inc. purchased 230,242 shares of Vuzix Corp's Series B Preferred Stock on 09/19/2025 at a price of $21.716 per share under the third closing of a securities purchase agreement dated September 3, 2024. Each Series B preferred share is convertible into 10 shares of Vuzix common stock, representing 2,302,420 underlying common shares. The Form 4 was filed as a single reporting person and lists Quanta as a director-related reporting person; the form is signed by C.C. Leung on 09/23/2025.
Vuzix Corp reporting person Christopher Iain Parkinson filed an initial Form 3 disclosing direct ownership of 2,250 shares of Vuzix common stock (ticker: VUZI). The filing lists Parkinson's address in West Henrietta, NY and his role as President, Vuzix Enterprise Solutions and an officer/director of the issuer. The reported event date is 09/03/2025 and the form is signed 09/19/2025.
Quanta Computer Inc. reports beneficial ownership of 9,589,477 shares of Vuzix common stock, representing 12.3% of the outstanding class. This total consists of 7,692,307 shares of common stock plus 1,897,170 shares that are convertible from 189,717 Series B Preferred Stock held by Quanta, with a stated conversion ratio of ten common shares per Series B share. The filing notes the Series B Preferred Stock generally does not carry voting rights except for limited matters requiring the consent of holders of two-thirds of the Series B, and Quanta certifies the stake was not acquired to change or influence control of the issuer.
FAQ
What is the current stock price of Vuzix (VUZI)?
What is the market cap of Vuzix (VUZI)?
